ASCOLT is an international multi-centre randomized placebo controlled trial that aims to evaluate the benefit of 3 yrs of adjuvant aspirin in patients who have already completed standard therapy for colorectal cancer. It is an investigator initiated study partnership across institutions in Asia and Australia – to address an important clinical question.